1
Gordon Allan, Brian Meehan, Edward Clark, John Ellis, Deborah Haines, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly: Porcine circoviruses vaccines diagnostic reagents. Merial, The Queen&apos s University of Belfast, University of Saskatchewan, William S Frommer, Thomas J Kowalski, Frommer Lawrence & Haug, May 21, 2002: US06391314 (85 worldwide citation)

The invention relates to new porcine circovirus strains isolated from pulmonary or ganglionic samples obtained from farms affected by the post-weaning multisystemic wasting syndrome (PMWS). It relates to purified preparations of these strains, conventional attenuated or inactivated vaccines, recombi ...


2
Gordon Moore Allan, Brian Martin Meehan, John Albert Ellis, George Steven Krakowka, Jean ChrJistophe Francis Audonnet: Porcine circovirus and paravovirus vaccine. Merial, The Queen&apos s University of Belfast, University of Saskatchewan, William S Frommer, Thomas J Kowalski, Frommer Lawrence & Haug, April 17, 2001: US06217883 (79 worldwide citation)

The invention relates to antigenic preparations and vaccines directed against the porcine multisystemic wasting syndrome (PMWS), comprising at least one porcine circovirus antigen, preferably type II, and at least one porcine parvovirus antigen.


3
Gordon Allan, Brian Meehan, Edward Clark, John Ellis, Deborah Haines, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly: Porcine circovirus vaccine and diagnostics reagents. Merial, The Queen&apos s University of Belfast, University of Saskatchewan, William S Frommer, Thomas J Kowalski, Frommer Lawrence & Haug, April 9, 2002: US06368601 (75 worldwide citation)

The invention relates to new porcine circovirus strains isolated from pulmonary or ganglionic samples obtained from farms affected by the post-weaning multisystemic wasting syndrome (PMWS). It relates to purified preparations of these strains, conventional attenuated or inactivated vaccines, recombi ...


4
John Albert Ellis, Gordon Allan Moore, Brian Meehan, Edward Clark, Deborah Haines, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, George Steve Krakowka, Jean Christophe Francis Audonnet, Francis McNeilly: Reduction of porcine circovirus-2 viral load with inactivated PCV-2. Merial, University of Saskatchewan, The Queen&apos s University of Belfast, William S Frommer, Thomas J Kowalski, Frommer Lawrence & Haug, February 11, 2003: US06517843 (57 worldwide citation)

Porcine circovirus-2 (PCV-2) is a recently identified agent wherein the potential spectrum of PCV-2-associated disease has been expanded by evidence of vertical and sexual transmission and associated reproductive failure in swine populations. PCV-2 was isolated from a litter of aborted piglets from ...


5
Gordon Allan, Brian Meehan, Edward Clark, John Ellis, Deborah Haines, Lori Hassard, John Harding, Catherine Elisabeth Charreyre, Gilles Emile Chappuis, Francis McNeilly: Porcine circoviruses, vaccines and diagnostic reagents. Merial, The Queen&apos s University of Belfast, University of Saskatchewan, William S Frommer, Thomas J Kowalski, Frommer Lawrence & Haug, December 9, 2003: US06660272 (54 worldwide citation)

The invention relates to new porcine circovirus strains isolated from pulmonary or ganglionic samples obtained from farms affected by the post-weaning multisystemic wasting syndrome (PMWS). It relates to purified preparations of these strains, conventional attenuated or inactivated vaccines, recombi ...


6
Qiang Liu, Suresh K Tikoo, Philip Willson, Lorne A Babiuk: Methods to culture circovirus. University of Saskatchewan, Morrison & Foerster, September 21, 2004: US06794163 (48 worldwide citation)

The present invention relates to methods for culturing circovirus and in particular, porcine circovirus. The present invention provides compositions and methods for culturing porcine circovirus in mammalian cells expressing mammalian adenovirus E1 functional protein.


7
Lipford Grayson B, Mookherjee Neeloffer, Babiuk Lorne, Brownlie Robert, Griebel Philip, Mutwiri George, Hecker Rolf: (tlr9) From various mammalian species. Coley Pharmaceutical, University Of Saskatchewan, Qiagen, Lipford Grayson B, Mookherjee Neeloffer, Babiuk Lorne, Brownlie Robert, Griebel Philip, Mutwiri George, Hecker Rolf, STEELE Alan W, April 1, 2004: WO/2004/026888 (47 worldwide citation)

Novel amino acid and nucleotide sequences for rat, pig (porcine), cow (bovine), horse (equine), and sheep (ovine) Toll-­like receptor 9 (TLR9) are provided. Also provided are amino acid and nucleotide sequences for dog (canine), cat (feline), mouse (murine), and human TLR9. Comparison of these seque ...


8
Stephen M Attree, Lawrence C Fowke: Desiccated conifer somatic embryos. University of Saskatchewan, Foley & Lardner, November 7, 1995: US05464769 (42 worldwide citation)

Conifer somatic embryos can be desiccated to a moisture content below 50%. A moisture content as low as 10% can be produced. The desiccated somatic conifer embryos have greatly increased ability to store lipids and other nutrients as compared to the corresponding zygotic embryo. The embryos are desi ...


9
Marta I Sabara, Patrick J Frenchick, Kerry F Mullin Ready: Rotavirus nucleocapsid protein VP6 as a carrier in vaccine compositions. University of Saskatchewan, Irell & Manella, December 10, 1991: US05071651 (37 worldwide citation)

Immunological carrier complexes are provided utilizing the VP6 polypeptide from rotavirus as the carrier molecule. Also provided are methods of binding epitope-bearing molecules (e.g., haptens) to the VP6 carrier molecule through binding peptides. The VP6 carrier can be a VP6 monomer, oligomer, or a ...


10
Sylvia van Drunen Littel van den Hurk, Timothy Zamb, Mark J Redmond: Adjuvant formulation with enhanced immunogenic activity, and related compositions and methods. University of Saskatchewan, Robins & Associates, September 14, 1999: US05951988 (32 worldwide citation)

Adjuvant formulations are provided containing quaternary ammonium salts in conjunction with an oil component which may be a mineral oil, an animal oil, a vegetable oil, a mixture thereof, or an oil-in-water emulsion of one or more of such oils. These formulations are useful in conjunction with known ...